Table of Content

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Polymers
3.2.1 Historical Development of Polymers
3.2.2 Properties of Polymers
3.2.2.1 Physical Properties
3.2.2.1 Chemical Properties
3.2.2.2 Mechanical Properties
3.2.3 Classification of Polymers
3.2.3.1 Classification based on Molecular Forces
3.2.3.2 Classification based on Origin of Source
3.2.3.3 Classification based on Structure of Molecular Chain
3.2.3.4 Classification based on Monomers
3.2.3.5 Classification based on Backbone Chain
3.2.3.6 Classification based on Degradation Capability
3.2.3.7 Classification based on Morphology
3.2.4 Applications of Polymers in Pharmaceutical / Medical Domain
3.2.4.1 Pharmaceutical Formulation
3.2.4.2 Drug Delivery System
3.2.4.3 Gene Therapy
3.2.4.4 Stability Enhancer
3.2.4.5 Vaccine Adjuvant
3.2.4.6 Tissue Engineering
3.2.4.7 Dentistry
3.2.4.8 Packaging
3.2.4.9 Medical Device Coating
3.2.4.10 Others
3.3. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Polymer / Medical Polymer Manufacturers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Source of Polymer
4.2.6. Analysis by Composition of Polymer
4.2.7. Analysis by Type of Polymer
4.2.8. Analysis by Area of Application

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Pharmaceutical Polymer / Medical Polymer Manufacturers: Company Competitiveness Analysis
5.4.1. Company Competitiveness Analysis: Players based in North America
5.4.2. Company Competitiveness Analysis: Players based in Europe
5.4.3. Company Competitiveness Analysis: Players based in Asia Pacific and Rest of the World

6. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Americhem
6.2.1. Company Overview
6.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Celanese
6.3.1. Company Overview
6.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Eastman
6.4.1. Company Overview
6.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Lubrizol Life Science
6.5.1. Company Overview
6.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. LyondellBasell
6.6.1. Company Overview
6.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.6.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN EUROPE
7.1. Chapter Overview
7.2. Borealis
7.2.1. Company Overview
7.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Henkel
7.3.1. Company Overview
7.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. KRAIBURG TPE
7.4.1. Company Overview
7.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. SEQENS
7.5.1. Company Overview
7.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Solvay
7.6.1. Company Overview
7.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN ASIA-PACIFIC AND REST OF THE WORLD
8.1. Chapter Overview
8.2. Corel Pharma Chem
8.2.1. Company Overview
8.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Kuraray
8.3.1. Company Overview
8.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. Phon Tech
8.4.1. Company Overview
8.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Sumitomo Chemical
8.5.1. Company Overview
8.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Zylog ElastoComp
8.6.1. Company Overview
8.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.6.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Composition of Polymer
9.3.5. Analysis by Type of Polymer
9.3.6. Analysis by Type of Partnership and Type of Polymer
9.3.7. Analysis by Area of Application
9.3.8. Analysis by Type of Partner
9.3.9. Most Active Players: Analysis by Number of Partnerships
9.3.10. Analysis by Geography
9.3.10.1. Intracontinental and Intercontinental Deals
9.3.10.2. International and Local Deals

10. PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS: DELT ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Key Parameters
10.3.1. Demographical Factors
10.3.2. Environmental Factors
10.3.3. Legal Factors
10.3.4. Technological Factors
10.4. DELT Analysis: Pharmaceutical Polymer / Medical Polymer Manufacturers
10.4.1. Arkema
10.4.2. Boron Molecular
10.4.3. Celanese
10.4.4. Chempilots
10.4.5. DSM
10.4.6. Evonik
10.4.7. Foryou Medical
10.4.8. JenKem Technology
10.4.9. Kraton
10.4.10. Kuraray
10.4.11. PolyVation
10.4.12. Polyzen
10.4.13. Zylog ElastoComp
10.5. Concluding Remarks

11. CASE STUDY: RECENT TRENDS RELATED TO PHARMACEUTICAL / MEDICAL POLYMERS
11.1 Chapter Overview
11.2 Recent Trends Related to Pharmaceutical / Medical Polymers
11.2.1 Development of Novel Pharmaceutical / Medical Polymers
11.2.1.1. Biodegradable Polymers
11.2.1.2. Smart Polymers
11.2.2. Recycling of Pharmaceutical / Medical Polymers
11.3. Concluding Remarks
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Pharmaceutical Polymers / Medical Polymers Market, 2023-2035
12.3.1. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Type of Polymer, 2023 and 2035
12.3.1.1. Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers, 2023-2035
12.3.1.2. Pharmaceutical Polymers / Medical Polymers Market for Elastomers, 2023-2035
12.3.1.3. Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers, 2023-2035
12.3.1.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.2. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Area of Application, 2023 and 2035
12.3.2.1. Pharmaceutical Polymers / Medical Polymers Market for Medical Devices, 2023-2035
12.3.2.2. Pharmaceutical Polymers / Medical Polymers Market for Excipients, 2023-2035
12.3.2.3. Pharmaceutical Polymers / Medical Polymers Market for Packaging, 2023-2035
12.3.2.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.3. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Geography, 2023 and 2035
12.3.3.1. Pharmaceutical Polymers / Medical Polymers Market in North America, 2023-2035
12.3.3.2. Pharmaceutical Polymers / Medical Polymers Market in Europe, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Asia-Pacific, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Latin America, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa, 2023-2035
13. CONCLUDING REMARKS
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Cassion Biotech
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Thomas A. Harlan, Chief Executive Officer and Paul L. Deangelis, Chief Scientist
14.3. Celares
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Michael Joachim Sefkow, Business Development Manager
14.4. Daikyo Seiko
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Risako Tanaka, Head of Marketing and Business Strategy

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS